| Literature DB >> 29845678 |
S Elbers1,2, H Wittink1, J J M Pool1, R J E M Smeets2,3.
Abstract
Generic self-management programs aim to facilitate behavioural adjustment and therefore have considerable potential for patients with chronic musculoskeletal pain. Our main objective was to collect and synthesize all data on the effectiveness of generic self-management interventions for patients with chronic musculoskeletal pain in terms of physical function, self-efficacy, pain intensity and physical activity. Our secondary objective was to describe the content of these interventions, by means of classification according to the Behaviour Change Technique Taxonomy. We searched PubMed, CENTRAL, Embase and Psycinfo for eligible studies. Study selection, data extraction and risk of bias were assessed by two researchers independently. Meta-analyses were only performed if the studies were sufficiently homogeneous and GRADE was used to determine the quality of evidence. We identified 20 randomized controlled trials that compared a self-management intervention to any type of control group. For post-intervention results, there was moderate quality evidence of a statistically significant but clinically unimportant effect for physical function and pain intensity, both favouring the self-management group. At follow-up, there was moderate quality evidence of a small clinically insignificant effect for self-efficacy, favouring the self-management group. All other comparisons did not indicate an effect. Classification of the behaviour change techniques showed large heterogeneity across studies. These results indicate that generic self-management interventions have a marginal benefit for patients with chronic musculoskeletal pain in the short-term for physical function and pain intensity and for self-efficacy in the long-term, and vary considerably with respect to intervention content. SIGNIFICANCE: This study contributes to a growing body of evidence that generic self-management interventions have limited effectiveness for patients with chronic musculoskeletal pain. Furthermore, this study has identified substantial differences in both content and delivery mode across self-management interventions.Entities:
Mesh:
Year: 2018 PMID: 29845678 PMCID: PMC6175326 DOI: 10.1002/ejp.1253
Source DB: PubMed Journal: Eur J Pain ISSN: 1090-3801 Impact factor: 3.931
Figure 1Flowchart of the literature search and study selection. n is the number of randomized controlled trials. FCT, forward citation tracking; BCT, backward citation tracking; Grey Lit, grey literature.
Characteristics of participants within the included studies
| Study | ( | Age | % female | Country | Pain duration, years | Diagnosis group |
|---|---|---|---|---|---|---|
| Andersen et al. ( | 141 | 45.23 (10.49) | 55.71 | Denmark | NR | Back pain or upper body pain |
| Arvidsson et al. ( | 202 | 55.48 (12.05) | 73 | Sweden | NR | Rheumatic diseases |
| Asenlof et al. ( | 122 | 42.56 (11.59) | 77.3 | Sweden |
| Musculoskeletal pain |
| Burckhardt et al. ( | 99 | 46.5 (8.3) | 100 | Sweden | 7.5 (5.5) | Fibromyalgia syndrome |
| Dworkin et al. ( | 124 | 37.7 (30.61) | 84.68 | United States | NR | Temporo‐mandibular disorders |
| Ersek et al. ( | 256 | 81.85 (6.48) | 84.75 | United States | NR | Chronic pain (>3 months) |
| Gronning et al. ( | 141 | 58 (11) | 69 | Norway | 12 (13) | Polyarthritis |
| Haas et al. ( | 120 | 77.2 (7.7) | 84.4 | United States | NR | Low back pain |
| Hutting et al. ( | 123 | 46.24 (10.89) | 75.9 | Netherlands | NR | Chronic non‐specific CANS |
| King et al. ( | 196 | 46.07 (9.05) | 100 | Canada | 9.33 (9.22) | Fibromyalgia syndrome |
| Knittle et al. ( | 78 | 62.75 (11.79) | 66.69 | Netherlands | NR | Rheumatoid arthritis |
| Lefort et al. ( | 110 | 39.48 (25–60) | 75 | Canada | 6.07 (1–28) | Non‐malignant chronic pain (>3 months) |
| Linton et al. ( | 103 | 50.73 (9.71) | 73.68 | Sweden | NR | Musculoskeletal pain |
| Manning et al. ( | 108 | 55.07 (15.55) | 75.93 | United Kingdom | 20 (18.52) | Rheumatoid arthritis |
| Moore et al. ( | 226 | 49.5 (10.6) | 54 | United States | NR | Back pain |
| Nicholas et al. ( | 141 | 73.9 (6.5) | 63 | Australia | 14.83 (17.3) | Chronic pain (>6 months) |
| Stuifbergen et al. ( | 234 | 53.09 (9.86) | 100 | United States | NR | Fibromyalgia syndrome |
| Taal et al. ( | 75 | 44.94 (24–64) | 73.68 | Netherlands | 4.3 (1–29) | Rheumatoid arthritis |
| Taylor et al. ( | 703 | 59.78 (13.67) | 67 | United Kingdom | NR | Chronic Musculoskeletal pain |
| Von Korff et al. ( | 255 | 49.8 (11.3) | 62.37 | United States | NR | Back pain |
NR, not reported.
Median.
Range.
Study characteristics of the included studies
| Study | Study characteristics | Measurement characteristics | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Setting | f2f sessions | Duration intervention | Total BCT | Type of control | Physical activity | Physical function | Self‐efficacy | Pain intensity | Post and f/u measurements | |
| Andersen et al. ( | NR | 6 group sessions | 15 h, within 6 weeks | 10 |
1. Physical activity | VAS |
1. f/u 3 month | |||
| Arvidsson et al. ( | NR | 10 group sessions | 15 h, within 1 year | 8 | Treatment as usual | SF‐36: PF |
1. post | |||
| Asenlof et al. ( | Physical Therapy Clinic | 8–10 sessions | Mean = 3.2 months | 10 | Exercise | PDI | SES | NRS |
1. post | |
| Burckhardt et al. ( | NR |
1. 6 group sessions |
1. 9 h, within 6 weeks | 13 | Waiting list | FIQ: Physical function | SES | Tender points | Post | |
| Dworkin et al. ( | Pain clinic | 3 group sessions | 3 h 15 m within 2.5 months | 15 | Treatment as usual | Pain interference score | NRS |
1. post | ||
| Ersek et al. ( | Retirement facility | 7 group sessions | 10 h 30 m | 14 | Workbook | RDQ | ASES | NRS |
1. post | |
| Gronning et al. ( | Hospital | 3 sessions, 1 individual session | 9 h 45 m | 9 | Treatment as usual | MHAQ | VAS |
1. f/u 4 month | ||
| Haas et al. ( | Community building | 6 group sessions | 15 h within six weeks | 13 | Waiting list | MvK: disability | NRS | f/u 6 month | ||
| Hutting et al. ( | NR | 6 group sessions | 15 h within 6 weeks | 14 | Treatment as usual | DASH | GES | NRS |
1. f/u 3 month | |
| King et al. ( | University |
1. Ed: 12 group sessions. |
1. Ed: 21 h | 11 |
1. Exercise | SES | Tenderpoints |
1. post | ||
| Knittle et al. ( | Hospital | 1 group session, 4 individual sessions | NR (Duration of individual sessions = 3 h 10 m) within 18 weeks | 18 | Education | SQuAsH | HAQ | Self‐efficacy for PA |
1. post | |
| Lefort et al. ( | Community setting | 6 group sessions | 12 h, within six weeks | 5 | Waiting list | 1. SF‐36: PF 2.SOPA‐D | SES | Post | ||
| Linton et al. ( | NR | 15 group sessions | 45 h, within 1 year | 7 |
1. Emotional support | MPI: general activity | SIP‐pain | MPI: pain severity | f/u 12 month | |
| Manning et al. ( | Hospital | 4 group sessions | 4 h, within 12 weeks | 16 | Treatment as usual | DASH | ASES: function | VAS |
1. post | |
| Moore et al. ( | NR | 2 group sessions, 1 individual session. | 2 h 48 m | 6 | Treatment as usual + self‐help book. | RDQ | NRS |
1. f/u 3 month | ||
| Nicholas et al. ( | Pain clinic | 8 group sessions | 16 h, within 4 weeks | 16 |
1. Exercise | RMDQ | PSEQ | NRS |
1. post | |
| Stuifbergen et al. ( | NR | 8 group sessions | 16 h within 5 months | 13 | Active control: 8 classroom sessions + phone calls | HPLPII: physical activity |
1. SF‐36: PCS | SRAHP |
1. post | |
| Taal et al. ( | NR | 6 group sessions | 15 h, within 6 weeks | 15 | Treatment as usual | AIMS: PA | MHAQ | ASES: function | AIMS: Pain |
1. post |
| Taylor et al. ( | Community buildings; hospitals; hospices; university premises | 3 day course | 16 h15 m, within 3 weeks | 26 | Treatment as usual + book and relaxation CD | CPG | PSEQ | CPG: pain intensity |
1. f/u 6 month | |
| Von Korff et al. ( | NR | 4 group sessions | 8 h, within 4 weeks | Treatment as usual + book. |
1. RDQ | NRS |
1. f/u 3 month | |||
AIMS, arthritis impact measuresment scales; ASES, arthritis self efficacy scale; CPG, chronic pain grade scale; DASH, disabilities of the arm shoulder and hand outcome measure; Ed, education; Ex, exercise; FIQ, fibromyalgia impact questionnaire; GES, general self‐efficacy scale; HAQ, health assessment questionnaire; HPLPII, health promoting lifestyle profileII; MHAQ, modified health assessment questionnaire; MPI, multidimensional pain inventory; MvK, modified von Korff scale; NR, not reported; NRS, numeric rating scale; PCS, physical component scale; PDI, pain disability index; RDQ, Roland Morris disability questionnaire; RMDQ, Roland Morris Disability Questionnaire; SES, self‐efficacy scale; SF‐36, short form 36; SIP, sickness impact profile; SOPA‐D, survey of pain attitudes, subscale disability; SquAsH, short questionnaire to assess health; SRAHP, self rated abilities for health practices scale; VAS, visual analogue scale.
Hours of face to face contact.
Average of the last seven days.
NRS of average pain score.
Not included in meta‐analysis.
Average of NRS rating ‘pain right now’, ‘worst pain’ and ‘usual pain’.
Pain in the previous week.
Average pain intensity in the preceding 3 months.
Figure 2Risk of bias assessment of included studies.
Figure 3Post treatment comparison of self‐management intervention versus control on physical function.
Figure 4Post treatment comparison of self‐management intervention versus control on self‐efficacy.
Figure 5Post treatment comparison of self‐management intervention versus control on pain intensity.
Figure 6Post treatment comparison of self‐management intervention versus control on physical activity.
GRADE evidence table for post‐intervention effects. Question: What is the short‐term effectiveness of self‐management interventions for patients with chronic pain compared to a control condition?
| Quality assessment | Number of patients | Effect | Quality | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Self‐management intervention | Control | Relative (95% CI) | Absolute (95% CI) | |
| Physical function (assessed with: questionnaires) | |||||||||||
| 8 | Randomized trials | Not serious | Not serious | Serious | Not serious | None | 501 | 545 | ‐ |
SMD 0.28 SD lower |
⨁⨁⨁◯ |
| Self efficacy (assessed with: questionnaires) | |||||||||||
| 8 | Randomized trials | Not serious | Serious | Serious | Not serious | None | 461 | 504 | ‐ | Not pooled |
⨁⨁◯◯ |
| Pain intensity (assessed with: questionnaires) | |||||||||||
| 5 | Randomized trials | Not serious | Not serious | Serious | Not serious | None | 311 | 248 | ‐ |
SMD 0.28 SD lower |
⨁⨁⨁◯ |
| Physical activity (assessed with: questionnaires; Scale from: 8 to 32) | |||||||||||
| 2 | Randomized trials | Not serious | Not serious | Serious | Serious | None | 142 | 132 | ‐ |
SMD 0.14 SD lower |
⨁⨁◯◯ |
CI, confidence interval; SMD, standardized mean difference.
Less than 25% of participants from high risk of bias studies.
Substantial overlap in confidence intervals.
I2 is more than 60%.
Substantial differences in interventions.
Substantial differences in outcome measures.
Total sample size is more than optimal information size (alpha = 0.05; Beta = 0.2; ES = 0.2 SD).
Limited overlap in confidence intervals.
I 2 is less than 60%.
Total sample size is less than optimal information size (alpha = 0.05; Beta = 0.2; ES = 0.2 SD).
Figure 7Follow‐up comparison of self‐management intervention versus control on physical function.
Figure 8Follow‐up comparison of self‐management intervention versus control on self‐efficacy.
Figure 9Follow‐up comparison of self‐management intervention versus control on pain intensity.
Figure 10Follow‐up comparison of self‐management intervention versus control on physical activity.
GRADE evidence table for follow‐up results. Question: What is the long‐term effectiveness of self‐management interventions for patients with chronic pain compared to a control condition?
| Quality assessment | Number of patients | Effect | Quality | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Self‐Management Intervention | Control | Relative (95% CI) | Absolute (95% CI) | |
| Physical function (follow‐up: range 6 months to 13 months; assessed with: questionnaires) | |||||||||||
| 12 | Randomized trials | Not serious | Not serious | Serious | Not serious | None | 1093 | 1064 | ‐ |
SMD 0.07 SD lower |
⨁⨁⨁◯ |
| Self‐efficacy (follow‐up: range 6 months to 13 months; assessed with: questionnaires) | |||||||||||
| 6 | Randomized trials | Not serious | Not serious | Serious | Not serious | None | 682 | 583 | ‐ |
SMD 0.13 SD lower |
⨁⨁⨁◯ |
| Pain (follow‐up: range 6 months to 13 months; assessed with: questionnaires) | |||||||||||
| 10 | Randomized trials | Not serious | Not serious | Serious | Not serious | None | 987 | 869 | ‐ |
SMD 0.04 SD lower |
⨁⨁⨁◯ |
| Physical activity (follow up: range 8 months to 12 months; assessed with: questionnaires) | |||||||||||
| 3 | Randomized trials | Not serious | Not serious | Serious | Serious | None | 154 | 156 | ‐ |
SMD 0.15 SD higher |
⨁⨁◯◯ |
CI, confidence interval; SMD, standardized mean difference.
Less than 25% of participants from high risk of bias studies.
Substantial overlap in confidence intervals.
I 2 is less than 60%.
Substantial differences in interventions.
Substantial differences in outcome measures.
Total sample size is more than optimal information size (alpha = 0.05, beta = 0.2, ES = 0.2 SD).
Total sample size is less than optimal information size (alpha = 0.05; Beta = 0.2; ES = 0.2 SD).